REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Samchundang Pharm. Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Samchundang Pharm. Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sam Chun Dang Pharm. Co., Ltd is a pharmaceutical company that focuses on developing global innovative medicines and is a provider for tablets, capsules, and injections in the OTC drug market.

Headquarters
904-1 Sangshin-Ri, Hyangnahm-Myun, Hwaseong-Gun
Hwaseong; Gyeonggi; Postal Code: 445-922

Contact Details: Purchase the Samchundang Pharm. Co.,Ltd. report to view the information.

Website: http://www.scd.co.kr

Basic Information
Total Employees:
Purchase the Samchundang Pharm. Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Samchundang Pharm. Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Samchundang Pharm. Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Samchundang Pharm. Co.,Ltd. report to view the information.
Incorporation Date:
December 29, 1943
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
8%
Subsidiaries
수인약품(주)
74%
삼천당제약(주)
31%
(주)소화
Company Performance
Financial values in the chart are available after Samchundang Pharm. Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
12.66%▲
Total operating revenue
12.65%▲
Operating profit (EBIT)
-23.4%▼
EBITDA
-11.17%▼
Net Profit (Loss) for the Period
N/A
Total assets
21.77%▲
Total equity
33.07%▲
Operating Profit Margin (ROS)
-1.77%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-16.65%▼
Quick Ratio
1.29%▲
Cash Ratio
1.07%▲

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Kolon Life Science Inc.
 
JW Life Science Corporation
Samil Pharm. Co.,Ltd.
 
Green Cross Lab Cell Corporation
Korea Arlico Pharm Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo